First Stereoselective Total Synthesis of Marliolide-(4R,5R,3E)-4-hydroxy-5-methyl-3-tetradecylidenedihydrofuran-2(3H)-one and Vittarilide-B: A Unified Strategy Utilizing a Chiral Pool Approach

被引:0
|
作者
Desireddi, Janardana Reddi [1 ,2 ]
Rao, Mora Mallikarjuna [3 ]
Murahari, Kiran Kumar [1 ]
Challa, Shivanagababu [4 ]
Maiti, Bhimcharan [1 ]
Manchal, Ravinder [2 ]
机构
[1] Aragen Life Sci Pvt Ltd, Med Chem Div, Hyderabad 500076, Telangana, India
[2] Deemed be Univ, Dept Chem, Hyderabad 500075, Telangana, India
[3] Sai Lifesciences Ltd, Proc Res & Dev Dept, Hyderabad 500078, Telangana, India
[4] Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA
来源
ACS OMEGA | 2025年 / 10卷 / 03期
关键词
ASYMMETRIC-SYNTHESIS; TUMOR INHIBITORS; LACTONES; ANALOGS; CYTOTOXICITY; CARBOHYDRATE; CONSTITUENTS; LITSENOLIDES; FAMILY; C-1;
D O I
10.1021/acsomega.4c10876
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The first stereoselective total synthesis of the natural products Marliolide-(4R,5R,3E)-4-hydroxy-5-methyl-3-tetradecylidenedihydrofuran-2(3H)-one (1) and Vittarilide-B (1b) has been accomplished using a carbohydrate-based approach starting from d-glucose. The synthesis of Marliolide-(4R,5R,3E)-4-hydroxy-5-methyl-3-tetradecylidenedihydrofuran-2(3H)-one (1) was achieved in 13 steps with an overall yield of 6.5%, featuring key transformations such as reduction, Wittig olefination, TEMPO-mediated oxidation, isomerization, and debenzylation. Vittarilide-B (1b) was synthesized in 18 steps with an overall yield of 8.8%, involving crucial steps like inversion, radical-mediated lactonization, Steglich esterification, and deprotection. The synthesis of Marliolide (1) led to the discovery of a notable isomerization phenomenon, where the Z -isomer was converted to the E -isomer during the oxidation step using BAIB and TEMPO. Various reaction conditions were investigated for this isomerization process, with the TEMPO-mediated reaction consistently providing the best results. The synthesis of Vittarilide-B (1b) required the inversion of stereochemistry at the C-2 position of the common intermediate 6b, followed by a sequence of steps to obtain the final product. The analytical data for both synthetic Marliolide-(4R,5R,3E)-4-hydroxy-5-methyl-3-tetradecylidenedihydrofuran-2(3H)-one (1) and Vittarilide-B (1b) were consistent with the data reported for the natural compounds. This work demonstrates the efficiency of using readily available chiral pool materials like d-glucose in the stereoselective synthesis of complex natural products and provides a foundation for further exploration of their biological activities and potential therapeutic applications.
引用
收藏
页码:3199 / 3205
页数:7
相关论文
共 50 条
  • [1] (3R,4R,5S)-4-Hydroxy-3-methyl-5-[(2S,3R)-3-methylpent-4-en-2-yl]-4,5-dihydrofuran-2(3H)-one
    Gille, Annika
    Schuermann, Markus
    Preut, Hans
    Hiersemann, Martin
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : O3274 - U2162
  • [2] (3S,4S,5R)-3-hydroxy-4-methyl-5-vinyltetrahydropyran-2-one
    Koerner, Marleen
    Schuermann, Markus
    Preut, Hans
    Hiersemann, M.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2007, 63 : O3012 - U3245
  • [3] Modified synthesis of methyl (1R,2R,3E,5R)-3-(hydroxyimino)-5-methyl-2-(1-methylethyl)-cyclohexanecarboxylate from (R)-4-menthen-3-one
    Ishmuratov, G. Yu.
    Bannova, A. V.
    Latypova, E. R.
    Muslukhov, R. R.
    Smol'nikov, A. A.
    Talipov, R. F.
    CHEMISTRY OF NATURAL COMPOUNDS, 2012, 48 (05) : 789 - 790
  • [4] Modified synthesis of methyl (1R,2R,3E,5R)-3-(hydroxyimino)-5-methyl-2-(1-methylethyl)-cyclohexanecarboxylate from (R)-4-menthen-3-one
    G. Yu. Ishmuratov
    A. V. Bannova
    E. R. Latypova
    R. R. Muslukhov
    A. A. Smol′nikov
    R. F. Talipov
    Chemistry of Natural Compounds, 2012, 48 : 789 - 790
  • [5] (3S,4S,5R)-4-Hydroxy-3-methyl-5-[(2S,3R)-3-methylpent-4-en-2-yl]-4,5-dihydrofuran-2(3H)-one
    Gille, Annika
    Blaeser, Dieter
    Boese, Roland
    Preut, Hans
    Hiersemann, Martin
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : O154 - U2600
  • [6] First stereoselective synthesis of (4aS,5R)-4,4a,5,6,7,8-hexahydro-4a,5-dimethyl-2(3H)-naphthalenone
    Cuesta, X
    González, A
    Bonjoch, J
    TETRAHEDRON-ASYMMETRY, 1999, 10 (17) : 3365 - 3370
  • [7] (2S*,3S*,4R*,5R*)-3,4,5-Trihydroxy-6-(hydroxy-methyl)-3,4,5,6-tetrahydro-2H-pyran-2-yl benzoate
    He, XJ
    Lobkovsky, E
    Liu, RH
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2006, 62 : O471 - O472
  • [8] Two new chiral nucleoside analogues:: (4R,5R)-4-(4,6-dimethylpyrimidin-2-ylsulfanyl)-5-[(2S,5R)-2-isopropyl-5-methylcyclohexyloxy]-2,3,4,5-tetrahydrofuran-2-one and (4R,5R)5-[(2S,5R)-isopropyl-5-methylcyclo-hexyloxy]-4-(4-methyl-1,3-thiazol-2-ylamino)-2,3,4,5-tetrahydrofuran-2-one
    He, L
    Liu, YM
    Zhang, W
    Chen, QH
    ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 2005, 61 : O390 - O392
  • [9] (3R,4aS,5R)-3-Hydroxy-5-isopropenyl-3,8-dimethyl-4,4a,5,6-tetrahydro-2(3H)-naphthalenone
    Ellis, DD
    Spek, AL
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 2001, 57 (57) : 497 - 498
  • [10] SYNTHESIS OF (3R,4S)- AND (3R,4R)-[4-2H,3H]VALINE - PREPARATION OF COMPOUNDS CONTAINING CHIRAL METHYL-GROUPS WITH AN ADJACENT ASYMMETRIC CENTER
    TOWNSEND, CA
    NEESE, AS
    THEIS, AB
    JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1982, (02) : 116 - 117